EP 2953633 A4 20160914 - CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Title (en)
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Title (de)
CD47-GEZIELTE THERAPIEN ZUR BEHANDLUNG VON INFEKTIONSKRANKHEITEN
Title (fr)
THÉRAPIES CIBLÉES SUR CD47 POUR LE TRAITEMENT D'UNE MALADIE INFECTIEUSE
Publication
Application
Priority
- US 201361761133 P 20130205
- US 2014014905 W 20140205
Abstract (en)
[origin: WO2014124028A1] Methods are provided for treating a subject with for an intracellular pathogen infection, by administering an agent that reduces the binding of CD47 on a infected cell to SIRPα on a host phagocytic cell, in an effective dose for increasing the phagocytosis of infected cells.
IPC 8 full level
A61K 35/00 (2006.01); A61P 31/12 (2006.01)
CPC (source: EP US)
A61K 38/1774 (2013.01 - EP US); A61P 31/12 (2018.01 - EP); C07K 16/2803 (2013.01 - EP US); C07K 16/2896 (2013.01 - US); A61K 2039/505 (2013.01 - EP US); C07K 2317/24 (2013.01 - EP US); C07K 2317/76 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP US)
Citation (search report)
- [A] WO 2011143624 A2 20111117 - UNIV LELAND STANFORD JUNIOR [US], et al
- [A] WO 2010130053 A1 20101118 - UNIV HEALTH NETWORK [CA], et al
- [I] SUPAPORN SUPARAK ET AL: "-induced cell fusion in U937 macrophages can be inhibited by monoclonal antibodies against host cell surface molecules", MICROBES AND INFECTION, ELSEVIER, PARIS, FR, vol. 13, no. 12, 10 June 2011 (2011-06-10), pages 1006 - 1011, XP028303524, ISSN: 1286-4579, [retrieved on 20110706], DOI: 10.1016/J.MICINF.2011.06.007
- See also references of WO 2014124028A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2014124028 A1 20140814; CA 2900256 A1 20140814; CA 2900256 C 20230321; DK 3311824 T3 20200414; EP 2953633 A1 20151216; EP 2953633 A4 20160914; EP 2953633 B1 20171004; EP 3311824 A1 20180425; EP 3311824 B1 20200325; EP 3721888 A1 20201014; EP 3721888 B1 20220720; EP 4119153 A1 20230118; EP 4119153 B1 20240424; EP 4119153 C0 20240424; ES 2649165 T3 20180110; ES 2794700 T3 20201118; ES 2928001 T3 20221114; HR P20200565 T1 20200807; PL 3721888 T3 20230411; PT 3721888 T 20221102; SI 3721888 T1 20230428; US 10184004 B2 20190122; US 10723803 B2 20200728; US 11230607 B2 20220125; US 11780931 B2 20231010; US 2015376288 A1 20151231; US 2017362332 A1 20171221; US 2019092873 A1 20190328; US 2020354469 A1 20201112; US 2022098322 A1 20220331; US 2023406952 A1 20231221; US 9771428 B2 20170926
DOCDB simple family (application)
US 2014014905 W 20140205; CA 2900256 A 20140205; DK 17194591 T 20140205; EP 14748994 A 20140205; EP 17194591 A 20140205; EP 20163565 A 20140205; EP 22185801 A 20140205; ES 14748994 T 20140205; ES 17194591 T 20140205; ES 20163565 T 20140205; HR P20200565 T 20200407; PL 20163565 T 20140205; PT 20163565 T 20140205; SI 201431994 T 20140205; US 201414763758 A 20140205; US 201715676296 A 20170814; US 201816214507 A 20181210; US 202016902068 A 20200615; US 202117550881 A 20211214; US 202318458903 A 20230830